Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple's disease.

Bibliographic Details
Title: Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple's disease.
Authors: Williamson, Katrina A1, Yun, Mark2, Koster, Matthew J1, Arment, Courtney1, Patnaik, Asha2, Chang, Tara W3, Bledsoe, Adam C4, Sae-Tia, Sutthichai5, Shah, Aditya S6, Samuels, Jonathan7, Davis, John M1 Qingping.yao@stonybrookmedicine.edu, Yao, Qingping2 Qingping.yao@stonybrookmedicine.edu
Source: Rheumatology. May2024, Vol. 63 Issue 5, p1291-1296. 6p.
Subject Terms: *BIOPSY, *WHIPPLE'S disease, *MONOCYTES, *MACROPHAGES, *EXANTHEMA, *RHEUMATOID arthritis, *RETROSPECTIVE studies, *AUTOINFLAMMATORY diseases, *FEVER, *ENDOSCOPIC surgery, *DOXYCYCLINE, *NUCLEOTIDES, *GENES, *RESEARCH, *DISEASE susceptibility, *GENETIC mutation, *CASE studies, *DISEASE relapse, *HEALTH care teams, *PHENOTYPES, *GASTROINTESTINAL diseases, *BIOMARKERS, *MOLECULAR diagnosis, *ENDOSCOPY, *CEFTRIAXONE, *CELLS, *IMMUNOSUPPRESSION
Abstract: Objectives Whipple's disease (WD) results from infection of the bacteria Tropheryma whipplei (TW). This disease is characterized by macrophage infiltration of intestinal mucosa and primarily affects Caucasian males. Genetic studies of host susceptibility are scarce. Nucleotide-binding oligomerization domain containing protein 2 (NOD2) is an innate immune sensor, resides mainly in monocytes/macrophages and contributes to defence against infection and inflammatory regulation. NOD2 mutations are associated with autoinflammatory diseases. We report the association of NOD2 mutations with TW and WD for the first time. Methods A multicentre, retrospective study of three patients with WD was conducted. Patients received extensive multidisciplinary evaluations and were cared for by the authors. NOD2 and its association with infection and inflammation were schematically represented. Results All patients were Caucasian men and presented with years of autoinflammatory phenotypes, including recurrent fever, rash, inflammatory arthritis, gastrointestinal symptoms and elevated inflammatory markers. All patients underwent molecular testing using a gene panel for periodic fever syndromes and were identified to carry NOD2 mutations associated with NOD2 -associated autoinflammatory disease. Despite initially negative gastrointestinal evaluations, repeat endoscopy with duodenal tissue biopsy ultimately confirmed WD. After initial ceftriaxone and maintenance with doxycycline and/or HCQ, symptoms were largely controlled, though mild relapses occurred in follow-up. Conclusion Both NOD2 and TW/WD are intensively involved in monocytes/macrophages. WD is regarded as a macrophage disease. NOD2 leucin-rich repeat–associated mutations in monocytes/macrophages cause functional impairment of these cells and consequently may make the host susceptible for TW infection and WD, especially in the setting of immunosuppression. [ABSTRACT FROM AUTHOR]
Copyright of Rheumatology is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
More Details
ISSN:14620324
DOI:10.1093/rheumatology/kead372
Published in:Rheumatology
Language:English